Detalhe da pesquisa
1.
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America.
Clin Infect Dis
; 73(6): 1003-1012, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822015
2.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine
; 62: 102109, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533419
3.
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
Lancet Infect Dis
; 21(9): 1257-1270, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887209
4.
Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia.
Pediatr Infect Dis J
; 39(4): e30-e36, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040014